Eric Y Chuang

Eric Y. Chuang received the doctorate degree in cancer biology with toxicology and molecular genetics as two sub-specialties from Harvard University, in 1997, and his doctoral thesis was to study radiation-induced mutagenesis in human cells. After graduation, he stayed with Harvard as a postdoctoral fellow for one year. He then joined the Radiation Biology Branch of the National Cancer Institute (NCI), National Institutes of Health (NIH), as an IRTA fellow to study radiogenomics in Bethesda, Maryland. Next, he became the Head of Microarray Laboratory for Radiation Oncology Sciences Program with NCI. After working with the NIH for several years, he took a faculty position with National Taiwan University (NTU). In 2009, he joined the Radiation Research Program of Division of Cancer Treatment and Diagnosis with NCI as a program director to oversee a portfolio of NIH grants that included radiation-induced signaling pathways, molecular mechanisms, and normal tissue injuries, as well as radiation-related genomic studies. In 2011, he returned to NTU and served as the director of the Graduate Institute of Biomedical Electronics and Bioinformatics (BEBI) from 2012 to 2018. Currently, he is a professor of BEBI with NTU and serving as the general director, Biomedical Technology and Device Research Laboratories, Industrial Technology Research Institute, Hsinchu, Taiwan. Being an expert in genomic technologies, bioinformatics, cancer, radiation biology & oncology, biomedical engineering, and precision medicine, he has published more than 160 peer-reviewed papers in related fields. Moreover, he has been serving as an editorial board member of Scientific Reports and the editor-in-chief of Translation Cancer Research. Finally, he received his executive MBA degree in International Business Management from NTU, in June 2017.